← Open Payments lookup

JESSICA MUELLEMAN: Open Payments

NPI 1437912466 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$788 in 31 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $788

Food & beverage: $788
CompanyPaymentsAmount
UCB, Inc.4$185
Galderma Laboratories, L.P.2$155
SUN PHARMACEUTICAL INDUSTRIES INC.2$57
Amgen Inc.3$56
MAYNE PHARMA COMMERCIAL LLC6$49
Novartis Pharmaceuticals Corporation2$43
ABBVIE INC.2$36
Genentech USA, Inc.1$28
AstraZeneca Pharmaceuticals LP1$28
Regeneron Healthcare Solutions, Inc.1$24

Products named: Bimzelx, NEMLUVIO, ILUMYA, OTEZLA, COSENTYX, DUPIXENT, SKYRIZI, Xolair.

Industry payments across MO — which companies pay providers there.